194 related articles for article (PubMed ID: 22744917)
21. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
[TBL] [Abstract][Full Text] [Related]
22. Analysis of pediatric autologous PBSC apheresis and transplant: age is a major factor affecting post-transplant toxicity.
Dubrovsky L; McCarter RJ; Fry TJ; Wong E; Cheng Y; Perez-Albuerne ED
Pediatr Blood Cancer; 2012 Aug; 59(2):301-5. PubMed ID: 22180259
[TBL] [Abstract][Full Text] [Related]
23. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
24. Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.
Imaizumi M; Watanabe A; Kikuta A; Takano T; Ito E; Shimizu T; Tsuchiya S; Iinuma K; Konno T; Ohi R; Hayashi Y;
Tohoku J Exp Med; 2001 Oct; 195(2):73-83. PubMed ID: 11846211
[TBL] [Abstract][Full Text] [Related]
25. Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.
London WB; Bagatell R; Weigel BJ; Fox E; Guo D; Van Ryn C; Naranjo A; Park JR
Cancer; 2017 Dec; 123(24):4914-4923. PubMed ID: 28885700
[TBL] [Abstract][Full Text] [Related]
26. Factors Impacting Time to Engraftment in Patients With High-risk Neuroblastoma Following Autologous Stem Cell Transplant.
Hillier K; Cheng WS; Whittle SB; Krance R; Foster JH
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e569-e574. PubMed ID: 32032244
[TBL] [Abstract][Full Text] [Related]
27. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.
Kletzel M; Abella EM; Sandler ES; Williams LL; Ogden AK; Pollock BH; Wall DA
J Pediatr Hematol Oncol; 1998; 20(1):49-54. PubMed ID: 9482413
[TBL] [Abstract][Full Text] [Related]
28. Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer.
Pecora AL; Lazarus HM; Stadtmauer EA; Winter J; Van Vliet A; Berry D; Gray R; Jennis A; Goldberg S; Cooper BW; Preti R
Bone Marrow Transplant; 2001 Jun; 27(12):1245-53. PubMed ID: 11548842
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with
Suh JK; Koh KN; Min SY; Kim YS; Kim H; Im HJ; Namgoong JM; Kim DY; Ahn SD; Lee JJ; Seo JJ
Pediatr Transplant; 2020 Mar; 24(2):e13658. PubMed ID: 31960542
[TBL] [Abstract][Full Text] [Related]
30. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
[TBL] [Abstract][Full Text] [Related]
31. Busulfan and melphalan as consolidation therapy with autologous peripheral blood stem cell transplantation following Children's Oncology Group (COG) induction platform for high-risk neuroblastoma: early results from a single institution.
Soni S; Pai V; Gross TG; Ranalli M
Pediatr Transplant; 2014 Mar; 18(2):217-20. PubMed ID: 24341617
[TBL] [Abstract][Full Text] [Related]
32. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results.
Matthay KK; O'Leary MC; Ramsay NK; Villablanca J; Reynolds CP; Atkinson JB; Haase GM; Stram DO; Seeger RC
Eur J Cancer; 1995; 31A(4):572-5. PubMed ID: 7576971
[TBL] [Abstract][Full Text] [Related]
33. Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study.
Park JR; Scott JR; Stewart CF; London WB; Naranjo A; Santana VM; Shaw PJ; Cohn SL; Matthay KK
J Clin Oncol; 2011 Nov; 29(33):4351-7. PubMed ID: 22010014
[TBL] [Abstract][Full Text] [Related]
34. The Impact of
Park HJ; Choi JY; Kim BK; Hong KT; Kim HY; Kim IH; Cheon GJ; Cheon JE; Park SH; Kang HJ
Children (Basel); 2023 Dec; 10(12):. PubMed ID: 38136138
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II clinical trial of high-dose [
Kuroda R; Wakabayashi H; Araki R; Inaki A; Nishimura R; Ikawa Y; Yoshimura K; Murayama T; Imai Y; Funasaka T; Wada T; Kinuya S
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1574-1583. PubMed ID: 34837510
[TBL] [Abstract][Full Text] [Related]
36. A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
Monnereau-Laborde S; Munzer C; Valteau-Couanet D; Ansoborlo S; Coze C; Chastagner P; Rubie H; Demeocq F; Stephan JL; Hartmann O; Perel Y
Pediatr Blood Cancer; 2011 Dec; 57(6):965-71. PubMed ID: 21744481
[TBL] [Abstract][Full Text] [Related]
37. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
[TBL] [Abstract][Full Text] [Related]
38. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
Berthold F; Boos J; Burdach S; Erttmann R; Henze G; Hermann J; Klingebiel T; Kremens B; Schilling FH; Schrappe M; Simon T; Hero B
Lancet Oncol; 2005 Sep; 6(9):649-58. PubMed ID: 16129365
[TBL] [Abstract][Full Text] [Related]
39. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).
Sung KW; Ahn HS; Cho B; Choi YM; Chung NG; Hwang TJ; Im HJ; Jeong DC; Kang HJ; Koo HH; Kook H; Kim HK; Lyu CJ; Seo JJ; Shin HY; Yoo KH; Won SC; Lee KS
J Korean Med Sci; 2010 May; 25(5):691-7. PubMed ID: 20436703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
